Vaccination and Multiple Sclerosis – Current Situation
Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown not to be associated with increased risk of exacerbation. A personalized approach to immunization of this group of patients is required, taking account...
Gespeichert in:
| Veröffentlicht in: | Neuroscience and behavioral physiology 2022-05, Vol.52 (4), p.486-490 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 490 |
|---|---|
| container_issue | 4 |
| container_start_page | 486 |
| container_title | Neuroscience and behavioral physiology |
| container_volume | 52 |
| creator | Boyko, A. N. Sivertseva, S. A. Chemakina, D. S. Spirin, N. N. Bykova, O. V. Guseva, M. E. |
| description | Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown not to be associated with increased risk of exacerbation. A personalized approach to immunization of this group of patients is required, taking account of ongoing therapy and the nature of the course of illness. MS is not an absolute contraindication for vaccination against the new coronavirus infection. Vaccination can be with any of the currently authorized immunoformulations. |
| doi_str_mv | 10.1007/s11055-022-01265-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9296221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2694416927</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3669-6964013fdf7365e43d3e71511a46313e112aaa3e44572d33dfff4d242f06123e3</originalsourceid><addsrcrecordid>eNp9kbtOxDAQRS0EguXxA1SRaGgCM36uGyS04iUtouAhOsskDhhlk8VOkOj4B_6QL8H7EAgKqinm3Ks7cwnZRThAAHUYEUGIHCjNAakUuV4hAxSK5UOt71fJAECrHATXG2QzxmdIIjWEdbLBxFAJBTAgwztbFL6xnW-bzDZldtnXnZ_WLrsuahfa6GP2-f6RjfoQXNNl177r5_A2WatsHd3Ocm6R29OTm9F5Pr46uxgdj_OCSalzqSUHZFVZKSaF46xkTqFAtFwyZA6RWmuZ41woWjJWVlXFS8ppBRIpc2yLHC18p_3DxJVFChFsbabBT2x4M6315vem8U_msX01mmpJKSaD_aVBaF96Fzsz8bFwdW0b1_bRUKk5R6mpSujeH_S57UOTzptTiAphRtEFVaT3xOCq7zAIZlaMWRRjUjFmXozRScQWopjg5tGFH-t_VF870o6q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2694117107</pqid></control><display><type>article</type><title>Vaccination and Multiple Sclerosis – Current Situation</title><source>SpringerLink Journals - AutoHoldings</source><creator>Boyko, A. N. ; Sivertseva, S. A. ; Chemakina, D. S. ; Spirin, N. N. ; Bykova, O. V. ; Guseva, M. E.</creator><creatorcontrib>Boyko, A. N. ; Sivertseva, S. A. ; Chemakina, D. S. ; Spirin, N. N. ; Bykova, O. V. ; Guseva, M. E.</creatorcontrib><description>Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown not to be associated with increased risk of exacerbation. A personalized approach to immunization of this group of patients is required, taking account of ongoing therapy and the nature of the course of illness. MS is not an absolute contraindication for vaccination against the new coronavirus infection. Vaccination can be with any of the currently authorized immunoformulations.</description><identifier>ISSN: 0097-0549</identifier><identifier>EISSN: 1573-899X</identifier><identifier>DOI: 10.1007/s11055-022-01265-9</identifier><identifier>PMID: 35875700</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Age ; Antigens ; Autoimmune diseases ; Behavioral Sciences ; Biomedical and Life Sciences ; Biomedicine ; Coronaviruses ; Infections ; Infectious diseases ; Multiple sclerosis ; Neurobiology ; Neurosciences ; Vaccination ; Vaccines</subject><ispartof>Neuroscience and behavioral physiology, 2022-05, Vol.52 (4), p.486-490</ispartof><rights>Springer Nature Switzerland AG 2022</rights><rights>Springer Nature Switzerland AG 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3669-6964013fdf7365e43d3e71511a46313e112aaa3e44572d33dfff4d242f06123e3</citedby><cites>FETCH-LOGICAL-c3669-6964013fdf7365e43d3e71511a46313e112aaa3e44572d33dfff4d242f06123e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11055-022-01265-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11055-022-01265-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Boyko, A. N.</creatorcontrib><creatorcontrib>Sivertseva, S. A.</creatorcontrib><creatorcontrib>Chemakina, D. S.</creatorcontrib><creatorcontrib>Spirin, N. N.</creatorcontrib><creatorcontrib>Bykova, O. V.</creatorcontrib><creatorcontrib>Guseva, M. E.</creatorcontrib><title>Vaccination and Multiple Sclerosis – Current Situation</title><title>Neuroscience and behavioral physiology</title><addtitle>Neurosci Behav Physi</addtitle><description>Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown not to be associated with increased risk of exacerbation. A personalized approach to immunization of this group of patients is required, taking account of ongoing therapy and the nature of the course of illness. MS is not an absolute contraindication for vaccination against the new coronavirus infection. Vaccination can be with any of the currently authorized immunoformulations.</description><subject>Age</subject><subject>Antigens</subject><subject>Autoimmune diseases</subject><subject>Behavioral Sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Coronaviruses</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Multiple sclerosis</subject><subject>Neurobiology</subject><subject>Neurosciences</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>0097-0549</issn><issn>1573-899X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kbtOxDAQRS0EguXxA1SRaGgCM36uGyS04iUtouAhOsskDhhlk8VOkOj4B_6QL8H7EAgKqinm3Ks7cwnZRThAAHUYEUGIHCjNAakUuV4hAxSK5UOt71fJAECrHATXG2QzxmdIIjWEdbLBxFAJBTAgwztbFL6xnW-bzDZldtnXnZ_WLrsuahfa6GP2-f6RjfoQXNNl177r5_A2WatsHd3Ocm6R29OTm9F5Pr46uxgdj_OCSalzqSUHZFVZKSaF46xkTqFAtFwyZA6RWmuZ41woWjJWVlXFS8ppBRIpc2yLHC18p_3DxJVFChFsbabBT2x4M6315vem8U_msX01mmpJKSaD_aVBaF96Fzsz8bFwdW0b1_bRUKk5R6mpSujeH_S57UOTzptTiAphRtEFVaT3xOCq7zAIZlaMWRRjUjFmXozRScQWopjg5tGFH-t_VF870o6q</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Boyko, A. N.</creator><creator>Sivertseva, S. A.</creator><creator>Chemakina, D. S.</creator><creator>Spirin, N. N.</creator><creator>Bykova, O. V.</creator><creator>Guseva, M. E.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7TK</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220501</creationdate><title>Vaccination and Multiple Sclerosis – Current Situation</title><author>Boyko, A. N. ; Sivertseva, S. A. ; Chemakina, D. S. ; Spirin, N. N. ; Bykova, O. V. ; Guseva, M. E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3669-6964013fdf7365e43d3e71511a46313e112aaa3e44572d33dfff4d242f06123e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Antigens</topic><topic>Autoimmune diseases</topic><topic>Behavioral Sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Coronaviruses</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Multiple sclerosis</topic><topic>Neurobiology</topic><topic>Neurosciences</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boyko, A. N.</creatorcontrib><creatorcontrib>Sivertseva, S. A.</creatorcontrib><creatorcontrib>Chemakina, D. S.</creatorcontrib><creatorcontrib>Spirin, N. N.</creatorcontrib><creatorcontrib>Bykova, O. V.</creatorcontrib><creatorcontrib>Guseva, M. E.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuroscience and behavioral physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boyko, A. N.</au><au>Sivertseva, S. A.</au><au>Chemakina, D. S.</au><au>Spirin, N. N.</au><au>Bykova, O. V.</au><au>Guseva, M. E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccination and Multiple Sclerosis – Current Situation</atitle><jtitle>Neuroscience and behavioral physiology</jtitle><stitle>Neurosci Behav Physi</stitle><date>2022-05-01</date><risdate>2022</risdate><volume>52</volume><issue>4</issue><spage>486</spage><epage>490</epage><pages>486-490</pages><issn>0097-0549</issn><eissn>1573-899X</eissn><abstract>Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown not to be associated with increased risk of exacerbation. A personalized approach to immunization of this group of patients is required, taking account of ongoing therapy and the nature of the course of illness. MS is not an absolute contraindication for vaccination against the new coronavirus infection. Vaccination can be with any of the currently authorized immunoformulations.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>35875700</pmid><doi>10.1007/s11055-022-01265-9</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0097-0549 |
| ispartof | Neuroscience and behavioral physiology, 2022-05, Vol.52 (4), p.486-490 |
| issn | 0097-0549 1573-899X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9296221 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Age Antigens Autoimmune diseases Behavioral Sciences Biomedical and Life Sciences Biomedicine Coronaviruses Infections Infectious diseases Multiple sclerosis Neurobiology Neurosciences Vaccination Vaccines |
| title | Vaccination and Multiple Sclerosis – Current Situation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T08%3A50%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccination%20and%20Multiple%20Sclerosis%20%E2%80%93%20Current%20Situation&rft.jtitle=Neuroscience%20and%20behavioral%20physiology&rft.au=Boyko,%20A.%20N.&rft.date=2022-05-01&rft.volume=52&rft.issue=4&rft.spage=486&rft.epage=490&rft.pages=486-490&rft.issn=0097-0549&rft.eissn=1573-899X&rft_id=info:doi/10.1007/s11055-022-01265-9&rft_dat=%3Cproquest_pubme%3E2694416927%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2694117107&rft_id=info:pmid/35875700&rfr_iscdi=true |